Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Mutations at Val-889 and Arg-752 disrupt key interactions in the androgen receptor, affecting its function.

LX-38 is a safer drug option for hair loss and prostate issues without hormonal side effects.

Non-classic congenital adrenal hyperplasia is a common disorder causing symptoms like acne and infertility, and it's managed based on symptoms, not just test results. Treatment can improve fertility and reduce miscarriage risk.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

New compounds may soon be tested to treat excessive hair growth in women.

DGAT1 enzyme is crucial for healthy skin and hair by regulating retinoid levels.

New treatments for enlarged prostate are being developed, some of which may be more effective than current medications.

1 alpha,25-dihydroxy-vitamin D3 and calcipotriol speed up cell differentiation in hair follicles.

Benzo[c]quinolizin-3-ones are effective nonsteroidal inhibitors of human steroid 5α-reductase 1.

LX-38 is a safer drug option for treating prostate issues and hair loss without hormonal side effects.

Impaired androgen production in 46,XY DSDs causes ambiguous genitalia and requires long-term care.

Androgens regulate 5 alpha-reductase activity in hamster sebaceous glands.

The vitamin D receptor is involved in multiple body functions beyond calcium regulation, including immune response and rapid reactions not related to gene activity.

High-dose dutasteride reduces PMDD symptoms by stabilizing neurosteroid levels.

THH and PAD type III appear together early in hair growth, but deiminated THH appears later, suggesting another factor is involved.

Different mutations in the 5 alpha-reductase-2 gene were found in affected individuals in the Dominican Republic, suggesting no common ancestry.

Lack of 5α-Reductase type 1 can lead to insulin resistance and liver problems.

Natural herbal compounds might treat certain medical conditions by reducing DHT levels, but more research is needed to confirm their effectiveness and safety.

Some hair loss and prostate drugs might increase the risk of diabetes and heart disease.

The gene SDR5A1 is found in scalp hair of both hirsute and normal individuals, but it does not explain differences in hair growth.

Mouse hair cells respond to male hormones by growing less, and this can be stopped by certain blockers.

5α-reductase deficiency can cause ambiguous genitalia and gender dysphoria, treatable with testosterone.

1α,25-dihydroxyvitamin D3 directly affects cartilage growth and development.

A substance called compound-1 could help increase hair growth by maintaining prostaglandin levels in hair follicles.

A new gene mutation causes vitamin D resistance and rickets, treatable with calcium therapy.

Testosterone, progesterone, and levonorgestrel change enzyme levels related to fat production in hamster skin, which could affect skin oil and acne.

The new compounds may be more effective and cheaper than current treatments for conditions like baldness.

The compound 4c effectively inhibits the enzyme linked to hair loss.

The research identified and described a gene important for hormone conversion in endangered catfish, which varies in activity during different reproductive stages and after hormone treatment.

Compound 4 is a promising treatment for hair loss with low toxicity.